Loading...
Market
Will the new COVID-19 vaccine for babies be widely adopted by pediatricians by December 31, 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Surveys and reports from major pediatric associations and healthcare providers
Story
FDA Approves COVID-19 Vaccine for Babies Amid Summer Surge
Aug 29, 2024, 06:54 PM
The U.S. Food and Drug Administration (FDA) has approved a new COVID-19 vaccine for emergency use, targeting babies as young as six months old, despite unsupported claims of its efficacy and in the absence of an emergency. This approval comes amidst a summer surge in COVID-19 infections across the United States, with cases rising notably in regions such as the D.C. area. Despite the increase in infections, COVID-associated deaths remain at low levels compared to previous years. The new vaccine aims to address the latest variants, although its efficacy in reducing hospitalizations and deaths is debated. As the surge continues, discussions are emerging about potentially returning to pandemic measures seen in 2020.
View original story
Similar markets
High (>70%) • 25%
Moderate (50-70%) • 25%
Low (30-50%) • 25%
Very Low (<30%) • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Increase • 33%
Decrease • 33%
Remain the same • 34%
Yes • 50%
No • 50%
Mostly supportive • 25%
Mostly opposed • 25%
Divided opinion • 25%
Indifferent • 25%
Increased support for vaccinations • 25%
Decreased support for vaccinations • 25%
No significant change • 25%
Increased demand for alternative vaccines • 25%
mRNA vaccines • 25%
Non-mRNA vaccines • 25%
No specific recommendation • 25%
Other vaccine types • 25%
Yes • 50%
No • 50%
Increase significantly • 25%
Decrease significantly • 25%
Remain stable • 25%
Fluctuate • 25%
